Functional and Ultrasound Guided Resection of Glioblastoma (FUTURE-GB)
FUTURE-GB Trial (Functional and Ultrasound-guided Resection of Glioblastoma) A 2-Stage Trial. A Learning Phase Evaluation of Participating Centres, Followed by a Randomised, Controlled Multicentre Phase III Trial.
Sponsor: Efficacy and Mechanism Evaluation (EME) Programme
A NA clinical study on Glioma Glioblastoma Multiforme, this trial is ongoing. The trial is conducted by Efficacy and Mechanism Evaluation (EME) Programme and has accumulated 5 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Jan 2026 — Present [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2025 — Jan 2026 [monthly]
Recruiting NA
-
Sep 2024 — Sep 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jul 2022 — Jul 2024 [monthly]
Recruiting NA
First recorded
Nov 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Efficacy and Mechanism Evaluation (EME) Programme
- Imperial College Healthcare NHS Trust
- University of Oxford
For direct contact, visit the study record on ClinicalTrials.gov .